GLP-1 Medications and Weight Health: What Senior Care Employers Need to Know
GLP-1 medications have moved from a niche diabetes treatment to one of the fastest-growing cost drivers in employer pharmacy benefits — and one of the most requested benefits by employees. Here's what the evidence actually shows.
Obesity as a Chronic Condition
The American Medical Association formally recognizes obesity as a disease (Policy H-440.842, adopted 2013, reaffirmed 2022) rather than simply a risk factor or lifestyle issue. In June 2025, the AMA went further, passing a resolution supporting expanded access to anti-obesity medications. That shift in clinical framing is a big part of why more employers are treating GLP-1 coverage as a benefits-design question rather than a flat exclusion.
Medication Affordability and Employer Cost Trends
Coverage is expanding, but so is cost pressure — and both trends are accelerating together.
Coverage Is Expanding, Especially Among Large Employers
Among large employers (500+ workers), 44% covered GLP-1s for weight loss in 2024, up from 41% in 2023; among employers with 20,000+ workers, coverage reached 64% in 2024, up from 56%. Among employers with 200+ workers, 19% cover GLP-1s for weight loss (2025); among the largest employers (5,000+ workers), coverage jumped from 28% in 2024 to 43% in 2025.
Source: Mercer, National Survey of Employer-Sponsored Health Plans, Nov 2024; KFF 2025 Employer Health Benefits Survey / Peterson-KFF Health System Tracker, Oct 2025.
A Large Share of the Workforce Could Qualify
34% of non-elderly people with employer coverage — an estimated 36.2 million people nationally — have a BMI that would medically qualify them for a GLP-1. That's a meaningful share of any employer's population, including senior care organizations.
Source: KFF/Peterson-KFF Health System Tracker, Oct 2025.
Cost Impact Is Significant
Employer pharmacy benefit costs rose 7.7% in 2024, after an 8.4% increase in 2023, with GLP-1 utilization cited as a key driver. GLP-1s made up 10.5% of total annual employer pharmacy claims in 2025, up from 8.9% in 2024.
Source: Mercer, Nov 2024; International Foundation of Employee Benefit Plans, May 2025.
Coaching and Utilization-Management Program Models
Employers that cover GLP-1s are increasingly pairing coverage with structure rather than offering it without guardrails. Among employers covering GLP-1s, 34% now require a dietitian, case-manager, or lifestyle-program step before approving coverage, up from just 10% a year earlier. Tightening BMI thresholds and prior-authorization requirements are also becoming more common as plan sponsors try to manage cost while still offering the benefit responsibly.
Source: KFF/Peterson-KFF Health System Tracker, Oct 2025.
Nutrition Support and Long-Term Sustainability
Medication alone rarely produces a durable outcome. Employers exploring GLP-1 coverage are increasingly pairing it with nutrition counseling, coaching, and lifestyle support — both to improve long-term results for employees and to manage the utilization-management expectations described above. For a workforce already stretched thin on time, program design that fits into a caregiver's schedule matters as much as the medication itself.
Massachusetts Update: There is no Massachusetts law mandating private or commercial insurer coverage of GLP-1s for weight loss. In fact, the state is narrowing its own coverage: the GIC (the state employee and retiree health plan) ends GLP-1 weight-loss coverage effective July 1, 2026, and MassHealth is dropping coverage for the obesity-only indication effective July 3, 2026. This is useful context for benchmarking your own plan design — it is not a requirement that applies to your organization.
Source: Governor Healey FY2026 budget veto message, July 2025.
Want the full GLP-1 Employer Guide?
Our resource library includes a deeper walkthrough of program design options for GLP-1 coverage.
Wondering how this affects your renewal?
Request a review and we'll walk through what GLP-1 trends mean for your specific plan.